Green Journals

Year	A+	A	B
2026		✓	✓
2025		✓	✓
2024		✓	✓
2023		✓	✓
2021/2022		✓	✓
2020		✓	✓
2019	✓	✓	✓
2018		✓

Response to correspondence on ‘Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials’ by Annfeldt et al

Tommy K. Annfeldt, Tobias Haugegaard, Laura C. Coates et al.

2026-11 Vol. 85 Issue 11 Pages e123-e125

DOI: 10.1016/j.ard.2026.07.008

Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project

Sofia Ramiro, Dafne Capelusnik, Clementina López-Medina et al.

2026-11 Vol. 85 Issue 11 Pages 2087-2098

DOI: 10.1016/j.ard.2026.06.002

Performance of a triage approach for identification of patients with inflammatory rheumatic and musculoskeletal diseases among rheumatology referrals

Imke Redeker, Maria Zacharopoulou, Andrea Schmidt et al.

2026-11 Vol. 85 Issue 11 Pages 2174-2182

DOI: 10.1016/j.ard.2026.08.005

Response to correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’

Yuki Imai, Michihito Kono, Tomonori Ishii et al.

2026-11 Vol. 85 Issue 11 Pages e133-e134

DOI: 10.1016/j.ard.2026.05.002

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)

Georgios Filippou, Laura Pezzoni, Emilio Filippucci et al.

2026-11 Vol. 85 Issue 11 Pages 2277-2287

DOI: 10.1016/j.ard.2026.05.019

Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial

Mats Junek, Quazi Ibrahim, Peter A. Merkel et al.

2026-11 Vol. 85 Issue 11 Pages 2233-2240

DOI: 10.1016/j.ard.2026.08.020

Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during B-cell depletion in IgG4-related disease

Hyo Jae Kim, Min-Gang Kim, Seongryong Kim et al.

2026-11 Vol. 85 Issue 11 Pages 2263-2276

DOI: 10.1016/j.ard.2026.05.024

Broad screening of inflammation-associated proteins identifies serum CCL19 as a novel biomarker of disease activity in IgG4-related disease

Federica Bonaso, Bohang Jiang, Laura J Yockey et al.

2026-11 Vol. 85 Issue 11 Pages 2253-2262

DOI: 10.1016/j.ard.2026.03.015

Use of parenteral compared with oral glucocorticoids in early rheumatoid arthritis for chance of being off steroids and escalation of therapy at 1 year

Andreu Fernández-Codina, Susan J. Bartlett, Carter Thorne et al.

2026-11 Vol. 85 Issue 11 Pages 2129-2135

DOI: 10.1016/j.ard.2026.08.001

Response to correspondence on ‘Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis’ by Zhang et al

Agnes E M Looijen, Paco M J Welsing, Annette H M van der Helm-van Mil et al.

2026-11 Vol. 85 Issue 11 Pages e128-e130

DOI: 10.1016/j.ard.2026.04.013

Journal Report

Journal Information

Classification History

Recent Articles